Clinical Trial Update: Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 safety study of rapamycin in children with familial adenomatous polyposis, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Familial Adenomatous Polyposis | Phase 2 | Status: NOT_YET_RECRUITING